Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial
about
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress DisordersChronic Sleep Disruption and the Reexperiencing Cluster of Posttraumatic Stress Disorder Symptoms Are Improved by Olanzapine: Brief Review of the Literature and a Case-Based SeriesThe safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyDurability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.Pharmacological treatment of PTSD - established and new approachesPsychopharmacotherapy of posttraumatic stress disorderPharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic reviewThe Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary CarePost-traumatic stress disorder: evidence-based research for the third millennium.Alpha-2 receptor agonists for the treatment of posttraumatic stress disorderEffect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysisCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersTranslational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorderUnderstanding and meeting information needs for patients with posttraumatic stress disorder.PTSD: from neurobiology to pharmacological treatmentsPosttraumatic Stress Disorder: Overview of Evidence-Based Assessment and TreatmentAssessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)Differences in Intrusive Memory Experiences in Post-traumatic Stress Disorder after Single, Re- and Prolonged Traumatization.Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorderCombat posttraumatic stress disorder, substance use disorders, and traumatic brain injuryPharmacotherapy of PTSD: premises, principles, and prioritiesDeep brain stimulation of the basolateral amygdala for treatment-refractory combat post-traumatic stress disorder (PTSD): study protocol for a pilot randomized controlled trial with blinded, staggered onset of stimulationTraumatic stress: effects on the brainFunctional neuroimaging in post-traumatic stress disorder.A spiritual-hypnosis assisted treatment of children with PTSD after the 2002 Bali terrorist attack.Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.Changes in emotion regulation in adults with and without a history of childhood abuse following posttraumatic stress disorder treatmentPharmacotherapy for posttraumatic stress disorder: empirical review and clinical recommendations.Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder.Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?Review of sertraline and its clinical applications in psychiatric disorders.The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma StudyPhysical and psychosocial functioning following motor vehicle trauma: relationships with chronic pain, posttraumatic stress, and medication use.A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).Posttraumatic Stress Disorder and Acute Stress Disorder II: Considerations for Treatment and PreventionSymptomatic and syndromal anxiety and depression.History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).
P2860
Q21129280-FA741E30-A674-4170-BC25-C75884F2FD82Q22305681-063A2087-7D9A-4EDA-B191-E117139FC3D8Q24596917-59E40021-9BFC-4A89-B413-A074E1D624BAQ24606265-77E6BF10-2177-438F-989C-C3365C084FDEQ24620135-B922149E-3AEE-4B4E-B545-77A08C08837CQ24633256-17170C8A-BB3B-462C-99B1-EA198E16CD2CQ24657148-2F398CE5-0C21-4A65-80E0-3E60242FABEAQ24657469-931ED9E7-66DA-4B4D-BF1E-E393E4263A42Q24682953-A1102D2A-1A34-40BC-AD8A-90E0294F6EFCQ24812423-C647B8B8-9377-42BA-81D2-1111FAAAE30AQ26795806-581E51FD-7A43-437C-AC0E-947C51875C77Q26851668-9318049D-B50C-4A23-8ED9-66C1B595595CQ27009995-84D665D1-F5DE-4041-8285-FDA1EB61BE6EQ27026926-909E8DFA-BF22-489F-9EFD-42C119DEA6A2Q27311209-59D75E5C-040C-45D4-B9A2-5191603434BAQ28070159-5E03CA36-F747-46C6-8963-A61192955528Q28078814-1F4B31BA-C50A-40B3-8AFA-51A238D23D1EQ28385622-36891777-53DF-4F79-A067-FC48F4CF08F4Q30380190-EE171D56-590B-43E2-A7A5-5A57D6C90357Q30419977-BB21368C-9A9A-43CA-A0F6-E4B3D562FA96Q30428666-C3729D78-545F-40F7-85A0-D04D9B094407Q30433266-AC95575B-A049-4D3A-9D88-5FD1BC8C2940Q30479154-59CFE1E5-21DD-4317-A6CA-C4F4DF1F3C6AQ30587237-27EEF09C-9B86-4DA3-94CF-D8FF638AC481Q31099484-6D3D0675-20F0-4883-BCD5-B523F554531DQ31108821-13389D4E-7CDE-4491-9C0F-E7D36031A2D1Q33493145-32B04651-E865-4A1D-9EA7-AEC9C11B4AFBQ33590538-A0259209-EDFD-42A2-BEEE-5B11DC8827BBQ33969159-0A584B87-5F6E-4EB1-AF6B-D679CE56160EQ33988963-71BF45F8-827F-4D04-BD68-5741C7B6BBADQ34122994-B51BEA3C-97E7-4BE1-9FE8-EC8BEE5E5DC4Q34126472-D9043D52-87B1-4CDE-9B3F-65091C85EFE4Q34232131-BD9986B5-A404-4E2A-96B4-EF0461ECD377Q34241066-2D65A88E-272F-4656-9122-E2E04CC2CF82Q34308754-687B78C3-12EF-4FFC-9F31-B29B940FA828Q34309114-3A34EA2A-B7B9-4901-A1ED-9D8A9BE1A297Q34309474-6E17B23B-B58B-42EE-A50E-9FF710610C9DQ34359824-EBDBD7F1-5954-4940-962A-123FD757344FQ34415522-C7C4C56F-8834-4410-8DC9-BC2973E4F6ECQ34420092-70DD2538-D1B2-44F8-BCC6-CB271E3A9331
P2860
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Efficacy and safety of sertral ...... a randomized controlled trial
@ast
Efficacy and safety of sertral ...... a randomized controlled trial
@en
Efficacy and safety of sertral ...... a randomized controlled trial
@nl
type
label
Efficacy and safety of sertral ...... a randomized controlled trial
@ast
Efficacy and safety of sertral ...... a randomized controlled trial
@en
Efficacy and safety of sertral ...... a randomized controlled trial
@nl
prefLabel
Efficacy and safety of sertral ...... a randomized controlled trial
@ast
Efficacy and safety of sertral ...... a randomized controlled trial
@en
Efficacy and safety of sertral ...... a randomized controlled trial
@nl
P2093
P3181
P356
P1476
Efficacy and safety of sertral ...... a randomized controlled trial
@en
P2093
B Rothbaum
G M Farfel
T Pearlstein
P304
P3181
P356
10.1001/JAMA.283.14.1837
P407
P577
2000-04-12T00:00:00Z